We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $198M invested in Surgalign Holdings, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

12% more capital invested

Capital invested by funds: $177M → $198M (+$20.6M)

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

0% more funds holding

Funds holding: 109109 (0)

5% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 38

Holders
109
Holders Change
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
10
Increased
36
Reduced
38
Closed
9
Calls
$86K
Puts
Net Calls
+$86K
Net Calls Change
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$27.3M -$408 -3 -0%
BlackRock
2
BlackRock
New York
$21.5M -$1.06M -7,818 -5%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$20.4M +$726K +5,338 +4%
KAM
4
Krensavage Asset Management
New York
$20.1M +$122K +898 +0.6%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.2M +$878K +6,450 +9%
RSCM
6
Rock Springs Capital Management
Maryland
$8.97M
Renaissance Technologies
7
Renaissance Technologies
New York
$6.89M +$848K +6,232 +14%
HC
8
Hillman Company
Pennsylvania
$6.63M -$3.06M -22,499 -32%
RCM
9
Rutabaga Capital Management
Massachusetts
$5.17M +$2.57M +18,885 +102%
State Street
10
State Street
Massachusetts
$4.93M -$126K -927 -3%
FP
11
Foundry Partners
Minnesota
$4.8M -$292K -2,149 -6%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.54M +$19.3K +142 +0.4%
KIA
13
Kopp Investment Advisors
Minnesota
$4.05M -$111K -816 -3%
KCM
14
Kennedy Capital Management
Missouri
$4.03M +$457K +3,361 +13%
RA
15
Royce & Associates
New York
$3.54M +$645K +4,740 +23%
AL
16
AJO LP
Pennsylvania
$3.05M -$215K -1,579 -7%
Northern Trust
17
Northern Trust
Illinois
$3M -$86.8K -638 -3%
BCM
18
Bridgeway Capital Management
Texas
$2.79M +$46.3K +340 +2%
Millennium Management
19
Millennium Management
New York
$2.41M -$303K -2,228 -11%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.3M +$19.6K +144 +0.9%
Allianz Asset Management
21
Allianz Asset Management
Germany
$1.66M -$172K -1,263 -10%
WCM
22
Wedge Capital Management
North Carolina
$1.49M -$50.8K -373 -3%
AA
23
Ancora Advisors
Ohio
$1.3M +$12.4K +91 +1%
Morgan Stanley
24
Morgan Stanley
New York
$1.24M +$134K +985 +12%
AG
25
Algert Global
California
$1.18M +$236K +1,733 +25%

SRGA Hedge Fund Activity: Q1 2018 in Review

109 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2018, worth a combined $198M — up 12% from $177M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SRGA positions and 9 closed out — a net gain of 1 holder — while 36 added to existing stakes and 38 trimmed.

The largest buyer was Rutabaga Capital Management, adding an estimated $2.57M. The largest seller was Hillman Company, cutting an estimated $3.06M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $198M of Surgalign Holdings, Inc. Common Stock stock for Q1 2018, up 12% quarter-over-quarter.
  • 10 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2018 and 9 closed out, a net change of +1 holder.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2018 was Rutabaga Capital Management, an estimated $2.57M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2018 was Hillman Company, an estimated $3.06M sold.

Based on aggregated 13F filings for Q1 2018.